Acurex Biosciences Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 3

Acurex Biosciences General Information

Description

Operator of a pharmaceutical company intended to halt major neurodegenerative diseases. The company specializes in supporting the impairment of mitophagy, by which cells dispose of dysfunctional mitochondria, which plays a significant role in the pathogenesis of PD and other diseases, enabling medical facilities to identify druggable targets responsible for defects in mitophagy.

Contact Information

Website
www.acurex.com
Formerly Known As
CuraX Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 930 Brittan Avenue
  • San Carlos, CA 94070
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 930 Brittan Avenue
  • San Carlos, CA 94070
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Acurex Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 09-May-2025 Completed Pre-Clinical Trials
3. Early Stage VC 01-Mar-2023 Completed Pre-Clinical Trials
2. Grant 27-Apr-2022 $7M Completed Pre-Clinical Trials
1. Grant 30-Sep-2021 $450K Completed Startup
To view Acurex Biosciences’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Acurex Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a pharmaceutical company intended to halt major neurodegenerative diseases. The company specializes in suppo
Drug Discovery
San Carlos, CA
12 As of 2024

New Haven, CT
 

Eindhoven, Netherlands
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Acurex Biosciences Competitors (41)

One of Acurex Biosciences’s 41 competitors is Arvinas, a Formerly VC-backed company based in New Haven, CT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arvinas Formerly VC-backed New Haven, CT
Ambagon Therapeutics Venture Capital-Backed Eindhoven, Netherlands
Agenus Formerly VC-backed Lexington, MA
TME Pharma Formerly VC-backed Berlin, Germany
Ayala Pharmaceuticals Corporation Wilmington, DE
You’re viewing 5 of 41 competitors. Get the full list »

Acurex Biosciences Patents

Acurex Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022216386-A2 T-type calcium channel antagonists and uses thereof Inactive 04-Mar-2021
WO-2022216386-A3 T-type calcium channel antagonists and uses thereof Inactive 04-Mar-2021
WO-2022216386-A9 T-type calcium channel antagonists and uses thereof Inactive 04-Mar-2021 C07D471/04

Acurex Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Acurex Biosciences Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Regents of the University of California University
Innovations for Impact Impact Investing Minority
Michael J. Fox Foundation Limited Partner
To view Acurex Biosciences’s complete investors history, request access »

Acurex Biosciences FAQs

  • When was Acurex Biosciences founded?

    Acurex Biosciences was founded in 2019.

  • Where is Acurex Biosciences headquartered?

    Acurex Biosciences is headquartered in San Carlos, CA.

  • What is the size of Acurex Biosciences?

    Acurex Biosciences has 12 total employees.

  • What industry is Acurex Biosciences in?

    Acurex Biosciences’s primary industry is Drug Discovery.

  • Is Acurex Biosciences a private or public company?

    Acurex Biosciences is a Private company.

  • What is Acurex Biosciences’s current revenue?

    The current revenue for Acurex Biosciences is .

  • Who are Acurex Biosciences’s investors?

    Regents of the University of California, Innovations for Impact, and Michael J. Fox Foundation have invested in Acurex Biosciences.

  • Who are Acurex Biosciences’s competitors?

    Arvinas, Ambagon Therapeutics, Agenus, TME Pharma, and Ayala Pharmaceuticals are some of the 41 competitors of Acurex Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process